SCHEMBL7366510

SCHEMBL7366510

CC(C)(C)OC(=O)Nc1ccc(CBr)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA9 Q16790 1/20 0.44
CYP17A1 P05093 1/20 0.43
IDO1 P14902 2/20 0.43
MAPKAPK2 P49137 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
RAB9A P51151 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
POLB P06746 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
EPHX2 P34913 1/20 0.40
NR1H4 Q96RI1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3439959 0.89 CA12 (0.44) CA12CA1CA9CYP17A1MAPKAPK2
SCHEMBL2290216 0.87 CA12 (0.45) CA12CA1CA9CYP17A1IDO1
SCHEMBL6814479 0.86 CA12 (0.44) CA12CA1CA9CYP17A1IDO1
SCHEMBL6942064 0.86 CA12 (0.44) CA12CA1CA9CYP17A1IDO1
SCHEMBL7157865 0.85 CYP17A1 (0.45) CA12CA1CA9CYP17A1IDO1
SCHEMBL15177602 0.84 CA12 (0.45) CA12CA1CA9CYP17A1MAPKAPK2
SCHEMBL6681859 0.83 KMT2A (0.43) CA12CA1CA9CYP17A1IDO1
SCHEMBL16303890 0.82 EPHX1 (0.58) CA12CA1CA9NPC1HPGD
SCHEMBL22941494 0.82 CA12 (0.51) CA12CA1CA9CYP17A1POLB
SCHEMBL6814964 0.81 MAPT (0.56) CA12CA1CA9CYP17A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999021831-A1 TRICYCLIC COMPOUNDS AS CGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-05-06 WO disclosed